Literature DB >> 23597788

Disruption of the gut microbiome as a risk factor for microbial infections.

Arya Khosravi1, Sarkis K Mazmanian.   

Abstract

The discovery that microorganisms can be etiologic agents of disease has driven clinical, research and public health efforts to reduce exposure to bacteria. However, despite extensive campaigns to eradicate pathogens (via antibiotics, vaccinations, hygiene, sanitation, etc.), the incidence and/or severity of multiple immune-mediated diseases including, paradoxically, infectious disease have increased in recent decades. We now appreciate that most microbes in our environment are not pathogenic, and that many human-associated bacteria are symbiotic or beneficial. Notably, recent examples have emerged revealing that the microbiome augments immune system function. This review will focus on how commensal-derived signals enhance various aspects of the host response against pathogens. We suggest that modern lifestyle advances may be depleting specific microbes that enhance immunity against pathogens. Validation of the notion that absence of beneficial microbes is a risk factor for infectious disease may have broad implications for future medical practices.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23597788      PMCID: PMC5695238          DOI: 10.1016/j.mib.2013.03.009

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  37 in total

1.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

2.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

Authors:  Carles Ubeda; Ying Taur; Robert R Jenq; Michele J Equinda; Tammy Son; Miriam Samstein; Agnes Viale; Nicholas D Socci; Marcel R M van den Brink; Mini Kamboj; Eric G Pamer
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

3.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

4.  Commensal bacteria calibrate the activation threshold of innate antiviral immunity.

Authors:  Michael C Abt; Lisa C Osborne; Laurel A Monticelli; Travis A Doering; Theresa Alenghat; Gregory F Sonnenberg; Michael A Paley; Marcelo Antenus; Katie L Williams; Jan Erikson; E John Wherry; David Artis
Journal:  Immunity       Date:  2012-06-14       Impact factor: 31.745

5.  Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.

Authors:  Lawrence J Brandt; Olga C Aroniadis; Mark Mellow; Amy Kanatzar; Colleen Kelly; Tina Park; Neil Stollman; Faith Rohlke; Christina Surawicz
Journal:  Am J Gastroenterol       Date:  2012-03-27       Impact factor: 10.864

6.  Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.

Authors:  Shin Maeda; Li-Chung Hsu; Hongjun Liu; Laurie A Bankston; Mitsutoshi Iimura; Martin F Kagnoff; Lars Eckmann; Michael Karin
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

7.  Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells.

Authors:  Tonyia Eaves-Pyles; Christopher A Allen; Joanna Taormina; Alexander Swidsinski; Christopher B Tutt; G Eric Jezek; Martha Islas-Islas; Alfredo G Torres
Journal:  Int J Med Microbiol       Date:  2007-09-27       Impact factor: 3.473

8.  Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.

Authors:  Nobuhiko Kamada; Yun-Gi Kim; Ho Pan Sham; Bruce A Vallance; José L Puente; Eric C Martens; Gabriel Núñez
Journal:  Science       Date:  2012-05-10       Impact factor: 47.728

9.  Altering host resistance to infections through microbial transplantation.

Authors:  Benjamin P Willing; Anjalee Vacharaksa; Matthew Croxen; Teerawat Thanachayanont; B Brett Finlay
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

Review 10.  What are the consequences of the disappearing human microbiota?

Authors:  Martin J Blaser; Stanley Falkow
Journal:  Nat Rev Microbiol       Date:  2009-11-09       Impact factor: 78.297

View more
  59 in total

Review 1.  Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.

Authors:  Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 2.  Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Authors:  Charul Rajput; Alika Sarkar; Nidhi Sachan; Neeraj Rawat; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2021-01-05       Impact factor: 3.996

Review 3.  The microbiome in inflammatory bowel disease: current status and the future ahead.

Authors:  Aleksandar D Kostic; Ramnik J Xavier; Dirk Gevers
Journal:  Gastroenterology       Date:  2014-02-19       Impact factor: 22.682

Review 4.  Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome.

Authors:  Kirk Beebe; Brante Sampey; Steven M Watkins; Michael Milburn; Andrea D Eckhart
Journal:  Clin Transl Sci       Date:  2014-01-14       Impact factor: 4.689

5.  Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile.

Authors:  Jeremy R Duvall; Leanne Bedard; Adel M Naylor-Olsen; Abigail L Manson; Joshua A Bittker; Wenye Sun; Mark E Fitzgerald; Zhenmin He; Maurice D Lee; Jean-Charles Marie; Giovanni Muncipinto; Diane Rush; Deming Xu; Huisheng Xu; Mingliang Zhang; Ashlee M Earl; Michelle A Palmer; Michael A Foley; Joseph P Vacca; Christina A Scherer
Journal:  ACS Infect Dis       Date:  2017-03-07       Impact factor: 5.084

Review 6.  Engineering microbes for targeted strikes against human pathogens.

Authors:  In Young Hwang; Hui Ling Lee; James Guoxian Huang; Yvonne Yijuan Lim; Wen Shan Yew; Yung Seng Lee; Matthew Wook Chang
Journal:  Cell Mol Life Sci       Date:  2018-05-07       Impact factor: 9.261

7.  Disruption of the Gut Microbiome Increases the Risk of Periprosthetic Joint Infection in Mice.

Authors:  Christopher J Hernandez; Xu Yang; Gang Ji; Yingzhen Niu; Arvinth S Sethuraman; Joseph Koressel; Matthew Shirley; Michael W Fields; Susan Chyou; Thomas M Li; Marysol Luna; Rowan L Callahan; F Patrick Ross; Theresa T Lu; Ilana L Brito; Alberto V Carli; Mathias P G Bostrom
Journal:  Clin Orthop Relat Res       Date:  2019-11       Impact factor: 4.176

8.  The pathogen Batrachochytrium dendrobatidis disturbs the frog skin microbiome during a natural epidemic and experimental infection.

Authors:  Andrea J Jani; Cheryl J Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

9.  Skin bacterial diversity of Panamanian frogs is associated with host susceptibility and presence of Batrachochytrium dendrobatidis.

Authors:  Eria A Rebollar; Myra C Hughey; Daniel Medina; Reid N Harris; Roberto Ibáñez; Lisa K Belden
Journal:  ISME J       Date:  2016-01-08       Impact factor: 10.302

10.  Dietary Cellulose Supplementation Modulates the Immune Response in a Murine Endotoxemia Model.

Authors:  Valentina Di Caro; Jessica L Cummings; Alicia M Alcamo; Jon D Piganelli; Robert S B Clark; Michael J Morowitz; Rajesh K Aneja
Journal:  Shock       Date:  2019-04       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.